Christopher Stewart's Insider Trades & SAST Disclosures
Christopher Stewart's most recent trade in Bionano Genomics Inc was a trade of 50,000 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on May 12, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Christopher Stewart.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 12 May 2023 | 50,000 | 281,373 (0%) | 0% | 0.7 | 33,415 | Common Stock |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 490,000 | 490,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 105,000 | 231,373 (0%) | 0% | 0 | Common Stock | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 13 May 2022 | 60,000 | 121,579 (0%) | 0% | 0.6 | 33,600 | Common Stock |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2022 | 60,000 | 117,500 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 550,000 | 550,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 19 Nov 2021 | 22,500 | 55,500 (0%) | 0% | 0.6 | 12,600 | Common Stock |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2021 | 22,500 | 177,500 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 25,000 | 200,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.56 per share. | 26 May 2021 | 25,000 | 33,000 (0%) | 0% | 0.6 | 14,000 | Common Stock |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 6.00 per share. | 22 Jan 2021 | 8,000 | 8,000 (0%) | 0% | 6 | 48,000 | Common Stock |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 350,000 | 350,000 | - | - | Stock Option (Right to Buy) | |
| Bionano Genomics Inc | Christopher Stewart | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2020 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges